Fenbendazole, often called Fenben, is a broad-spectrum antiparasitic medication primarily used in veterinary medicine to treat parasitic worms in animals. It has attracted interest in cancer research because laboratory and animal studies have investigated potential effects on cancer cells. However, fenbendazole is not FDA approved as a human cancer treatment, and its effectiveness against cancer in people has not been established.
If you have been researching alternative or repurposed approaches to cancer, you may have come across the words fenbendazole or Fenben.
I did too.
After my cancer became stage 4, I began researching virtually everything I could find about cancer, metabolism, nutrition, immunotherapy, repurposed drugs, and integrative approaches. Fenbendazole was one of the substances that repeatedly appeared in my research.
But there is an important distinction I want to make at the beginning of this article:
Fenbendazole is not an FDA-approved cancer treatment, and it has not been proven in human clinical trials to cure or treat cancer.
Laboratory and animal research is investigating its potential anticancer properties, but that is very different from demonstrating that it works in people.
I use fenbendazole as one component of my own broader cancer strategy. At the same time, I have received conventional cancer treatment, including Keytruda immunotherapy, and have made significant changes to my nutrition and lifestyle.
My cancer subsequently shrank and became stable.
I cannot scientifically determine which individual component, or combination of components, produced those results.
This article therefore has two purposes: to explain what fenbendazole actually is and what the research currently tells us, and to share why I personally became interested in it after being diagnosed with stage 4 cancer.
This article describes my personal experience and research. It is not medical advice and should not be interpreted as a recommendation to take fenbendazole or any other medication.
What Is Fenbendazole?
Fenbendazole is a broad-spectrum benzimidazole antiparasitic medication primarily used in veterinary medicine to treat parasitic worms in animals. It is the active ingredient in veterinary products such as Panacur and Safe-Guard and is commonly used against parasites including roundworms, hookworms, whipworms, and certain other gastrointestinal parasites. Fenbendazole works against parasites by binding to tubulin and disrupting the formation of microtubules, which interferes with essential cellular functions and energy metabolism. In recent years, fenbendazole has attracted attention in cancer research because laboratory and animal studies have investigated whether some of these cellular effects may also affect cancer cells. Preclinical research has examined potential mechanisms involving microtubule disruption, glucose uptake, p53 activity, and cancer-cell death. However, fenbendazole is not FDA approved as a cancer treatment in humans, and laboratory or animal findings do not establish that fenbendazole safely or effectively treats cancer in people. [1][3][4][10]
What Is Fenben?
Fenben is a commonly used abbreviation or nickname for fenbendazole, a broad-spectrum benzimidazole antiparasitic medication primarily used in veterinary medicine to treat parasitic worms in animals. When people search online for “What is Fenben?”, “Fenben and cancer,” or “Fenben for cancer,” they are generally referring to fenbendazole rather than a separate drug or special formulation. The term Fenben has become increasingly common in cancer discussions because fenbendazole has been investigated in laboratory and animal studies for potential anticancer properties, including effects on microtubules, glucose metabolism, and cancer-cell survival. These preclinical findings have generated considerable interest among cancer patients and researchers, but Fenben is not an FDA-approved cancer treatment, and there is currently insufficient human clinical evidence to establish fenbendazole as a safe or effective treatment for cancer. [1][3][10]
Fenbendazole and Cancer
Fenbendazole and cancer have become increasingly associated in online searches because researchers have investigated whether the drug may affect biological processes involved in cancer-cell growth and survival. Laboratory and animal studies have examined potential effects involving microtubules, glucose metabolism, apoptosis and p53 activity. These findings make fenbendazole an interesting subject for further cancer research, but they do not establish that fenbendazole safely or effectively treats cancer in humans. Large randomized human clinical trials demonstrating a cancer-treatment benefit are currently lacking.
What Is Fenbendazole Normally Used For?
Fenbendazole was developed as an anthelmintic, meaning a medication used to kill or control parasitic worms.
Its established medical use is primarily veterinary.
That distinction matters.
A medication being used safely in animals does not automatically establish that the same medication, formulation or dose is safe or effective for humans.
Fenbendazole has attracted considerable attention outside veterinary medicine because researchers have observed biological effects that could potentially be relevant to cancer.
That is where the story becomes interesting, but it is also where we need to separate scientific evidence from speculation.
Why Are Cancer Patients Talking About Fenbendazole?
Fenbendazole became increasingly well known in cancer communities after stories circulated online about cancer patients who took it as part of their personal treatment strategies.
Perhaps the best-known example is Joe Tippens, whose story helped generate enormous interest in fenbendazole among cancer patients.
Stories like these can be compelling, particularly when you are facing advanced cancer.
I understand that personally.
When you hear the words stage 4, your perspective changes.
You start asking questions you may never have considered before.
What else is being researched?
Are there approaches outside standard treatment worth investigating?
Are researchers discovering unexpected anticancer effects in medications originally developed for something completely different?
Those are reasonable questions.
But individual success stories are not clinical trials.
Even dramatic outcomes cannot establish whether fenbendazole caused the improvement, whether another treatment caused it, whether several interventions worked together, or whether other factors were involved.
That same limitation applies to my own story.
Why Scientists Became Interested in Fenbendazole and Cancer
Fenbendazole belongs to the benzimidazole family of compounds.
Researchers have studied this class of compounds because of their effects on cellular structures and processes that can also be important to cancer cells.
Laboratory research has suggested several possible anticancer mechanisms involving fenbendazole.
These include:
1. Disrupting Microtubules
Microtubules are microscopic structures that form part of a cell’s internal skeleton.
They play important roles in cell shape, internal material transport, and cell division.
Cancer depends on uncontrolled cellular division.
Research published in Scientific Reports found that fenbendazole demonstrated microtubule-destabilizing activity in experimental cancer models.
Disrupting microtubules can interfere with a cell’s ability to divide properly.
This is particularly interesting because microtubules are already established targets for several conventional cancer medications.
However, laboratory activity does not establish that fenbendazole is an effective cancer treatment in humans.
2. Interfering With Glucose Metabolism
One of the most interesting findings involves glucose metabolism.
Cancer metabolism is complicated, and statements such as “sugar feeds cancer” can oversimplify the science. Normal cells also require glucose.
However, many cancers demonstrate altered glucose metabolism, including increased glucose uptake and glycolysis.
Researchers studying fenbendazole found reduced glucose uptake in certain cancer cells in laboratory experiments.
The researchers also reported changes involving GLUT transporters and hexokinase II, an enzyme involved in glucose metabolism.
That finding caught my attention because I had already become deeply interested in cancer metabolism and nutrition.
But again, there is an important qualifier:
Researchers observed these effects primarily in experimental models. We cannot assume the same effect produces meaningful tumor control in human cancer patients.
3. Promoting Apoptosis
Apoptosis is sometimes described as programmed cell death.
Healthy bodies have mechanisms for eliminating damaged or abnormal cells.
Cancer cells can acquire mechanisms that allow them to evade normal cell-death signals.
Preclinical research suggests fenbendazole may influence cellular pathways associated with apoptosis.
That makes it scientifically interesting.
It does not make it a proven cancer therapy.
4. Effects Involving p53
Researchers have also reported effects involving p53, an important tumor-suppressor protein.
Sometimes called the “guardian of the genome,” p53 helps control how cells respond to DNA damage and cellular stress.
Abnormalities involving p53 are common across many cancers.
Laboratory research into fenbendazole has reported p53-related activity alongside changes in microtubules and cellular metabolism.
These mechanisms provide legitimate reasons for scientists to investigate fenbendazole further.
They do not establish clinical effectiveness.
Fenbendazole and Cancer: What Does the Research Actually Show?
This is probably the most important section of this article.
When discussing repurposed drugs and cancer, we need to distinguish among several very different levels of evidence.
Laboratory Studies
Researchers can expose cancer cells growing in a laboratory to a substance and measure what happens.
Fenbendazole has demonstrated anticancer activity in several experimental settings.
These studies can help scientists identify mechanisms worth investigating.
But killing cancer cells in a laboratory is not equivalent to successfully treating cancer in a person.
Animal Studies
Researchers can also test potential treatments in animals or in mice carrying human tumor xenografts.
Fenbendazole has shown antitumor effects in some animal models.
That represents another level of evidence, but animal studies still cannot establish that a treatment will be safe or effective in humans.
Human Evidence
This is where the evidence becomes much weaker.
There are not large, randomized human clinical trials demonstrating that fenbendazole safely improves cancer survival, produces durable tumor responses or cures cancer.
That distinction needs to remain at the center of any responsible discussion of fenbendazole.
Promising laboratory evidence is not the same thing as proven human effectiveness.
Is Fenbendazole FDA Approved for Humans?
Fenbendazole is widely used in veterinary medicine and appears in FDA records for approved animal drugs.
That does not mean fenbendazole has been FDA approved as a human cancer treatment.
It has not.
This is important because FDA approval involves evaluating evidence concerning safety, effectiveness, manufacturing quality, dosing and other factors for a particular use.
Using an animal medication in a human introduces uncertainties that should not be dismissed simply because the medication has been widely used in animals.
Can Fenbendazole Cause Side Effects?
Yes.
One misconception surrounding repurposed drugs is that “not chemotherapy” means “harmless.”
That isn’t necessarily true.
The safety profile of fenbendazole in humans is not as well established as it is in the animals for which the medication was developed.
One published case report described an 80-year-old woman with advanced non-small-cell lung cancer who was receiving pembrolizumab and began self-administering fenbendazole after learning about it through social media.
She subsequently developed severe liver injury.
Her liver dysfunction resolved after fenbendazole was discontinued.
A case report cannot tell us how frequently this happens, but it demonstrates why potential toxicity should not be ignored.
Cancer patients may also be taking immunotherapy, chemotherapy, prescription medications, supplements or other substances, creating additional concerns about interactions and liver function.
This is one reason I strongly believe patients should discuss everything they are taking with their medical team.
Why I Considered Fenbendazole After My Stage 4 Diagnosis
My interest in fenbendazole wasn’t theoretical.
It became personal.
After years of cancer treatments, my cancer eventually became metastatic.
At that point, I began looking much deeper into the biology of cancer and into approaches that might complement conventional medical treatment.
My wife played an enormous role in that research.
We researched nutrition, metabolism, vitamin D, immunotherapy, repurposed medications and other integrative approaches.
Fenbendazole repeatedly appeared.
Initially, I was skeptical.
It was a veterinary antiparasitic medication being discussed as a potential cancer treatment.
That deserves skepticism.
But when I began reading the scientific literature rather than relying solely on social media stories, I found legitimate laboratory research involving microtubules, glucose metabolism and cancer-cell survival.
That didn’t prove fenbendazole would help me.
It did make me want to understand it better.
Fenbendazole Became One Part of a Much Larger Strategy
One thing I want readers to understand about my story is that I did not take fenbendazole in isolation.
My approach to stage 4 cancer involved multiple interventions.
My conventional medical treatment included immunotherapy.
At the same time, I made significant changes to my nutrition and lifestyle and explored several integrative approaches.
Fenbendazole was one piece of that much larger puzzle.
That matters tremendously when interpreting my results.
What Happened to My Cancer?
After beginning this broader strategy, subsequent CT scans showed significant improvement in my metastatic cancer.
Tumors shrank.
Some became difficult to detect.
Eventually, my cancer became stable.
Seeing those scan results after everything my family and I had been through was extraordinary.
I am deeply grateful for those results.
But gratitude and scientific certainty are two different things.
Did Fenbendazole Shrink My Cancer?
I don’t know.
That may be one of the most important sentences on this page.
I believe in being transparent about what happened to me without claiming that I can prove why it happened.
I was using multiple interventions.
I was receiving cancer treatment.
I changed my nutrition.
I made lifestyle changes.
I incorporated several integrative strategies.
And I took fenbendazole as part of that larger approach.
My tumors subsequently shrank.
Those are facts from my experience.
What I cannot scientifically say is:
“Fenbendazole caused my tumors to shrink.”
There is no way to isolate one variable from everything else I was doing.
Could fenbendazole have contributed?
It’s possible.
Could immunotherapy have been primarily responsible?
Absolutely.
Could multiple factors have interacted?
That’s possible too.
That uncertainty is precisely why human clinical research matters.
Why I Still Talk About Fenbendazole
So why write about it at all?
Because cancer patients are already searching for it.
They are hearing the word Fenben on social media, in cancer groups, from friends and from other patients.
Some will encounter extraordinary claims.
Others will encounter people dismissing the subject without discussing why scientists have studied fenbendazole in the first place.
I think patients deserve something better than either extreme.
They deserve to know:
There is legitimate preclinical research.
There are interesting biological mechanisms being investigated.
There are compelling personal stories.
There are also serious limitations in the evidence.
Human safety is not adequately established for cancer treatment.
Fenbendazole is not an FDA-approved cancer therapy.
And nobody should confuse someone’s personal cancer story, including mine, with proof of effectiveness.
Questions I Would Ask Before Considering Any Repurposed Drug
My experience with cancer has taught me to ask better questions.
If you are researching fenbendazole or another repurposed drug, consider discussing questions like these with your oncologist or qualified medical professional:
- What human evidence exists?
- Is the evidence laboratory, animal or clinical?
- Are there known liver or kidney risks?
- Could it interact with my cancer treatment?
- Could it interfere with immunotherapy or chemotherapy?
- What bloodwork would be important to monitor?
- Are there clinical trials investigating this approach?
- What don’t researchers currently know?
Most importantly, make sure your medical team knows what you are taking.
Fenbendazole Frequently Asked Questions
What is Fenben?
Fenben is an informal abbreviation commonly used for fenbendazole, a veterinary antiparasitic medication.
What is fenbendazole used for?
Fenbendazole is primarily used in veterinary medicine to treat certain parasitic worms in animals.
Is Fenben the same as fenbendazole?
Generally, yes. “Fenben” is commonly used online as shorthand for fenbendazole.
Is fenbendazole a cancer drug?
Fenbendazole has been investigated in laboratory and animal cancer research, but it is not an FDA-approved cancer treatment and has not been established as an effective cancer therapy through large human clinical trials.
Does fenbendazole kill cancer cells?
Fenbendazole has shown anticancer effects against certain cancer cells in laboratory research and antitumor activity in some animal models.
That does not establish that it effectively treats cancer in humans.
How might fenbendazole affect cancer cells?
Preclinical studies have investigated several potential mechanisms, including disruption of microtubules, changes in glucose metabolism, p53-related activity and apoptosis.
These mechanisms remain areas of research rather than proof of clinical effectiveness.
Does fenbendazole starve cancer cells of glucose?
Laboratory research has found that fenbendazole can reduce glucose uptake and alter glucose-related pathways in certain cancer cells.
Calling this simply “starving cancer” is an oversimplification. Researchers have not demonstrated that taking fenbendazole produces a clinically meaningful glucose-starvation effect against tumors in humans.
Is fenbendazole FDA approved?
Fenbendazole is used in FDA-approved veterinary drug products. It is not FDA approved as a human cancer treatment.
Can fenbendazole cause liver damage?
Published medical literature includes at least one case of serious liver injury associated with self-administered fenbendazole in a cancer patient. The frequency and overall safety profile of fenbendazole use in humans are not adequately established.
Did fenbendazole cure Wayne’s cancer?
No such conclusion can be made.
Fenbendazole was one component of my larger strategy, which also included conventional medical treatment and other interventions. My metastatic tumors significantly decreased and subsequently became stable, but I cannot scientifically attribute those results to fenbendazole.
The Bottom Line: What We Know and What We Don’t
Fenbendazole fascinates me precisely because the story isn’t finished.
We know it is an established veterinary antiparasitic medication.
We know laboratory researchers have identified mechanisms involving microtubules, glucose metabolism and cancer-cell survival.
We know some animal research has demonstrated antitumor activity.
We also know something equally important:
We do not currently have strong human clinical evidence demonstrating that fenbendazole safely and effectively treats cancer.
Those two realities can exist simultaneously.
My own cancer journey has taught me to remain curious without confusing hope with proof.
I researched fenbendazole.
I decided to incorporate it into my personal strategy.
My cancer subsequently responded dramatically to the overall treatment approach I was following.
I am grateful for that every single day.
But my story is one person’s experience, not a clinical trial.
If future research determines that fenbendazole has a legitimate role in human cancer treatment, I will be fascinated to see where the science leads.
Until then, I believe cancer patients deserve accurate information, honest discussion, and the freedom to ask difficult questions while working with qualified medical professionals.
My goal with Wayne’s Cancer Journey is to share what I have learned, what I have experienced, and what the research actually says so that other people facing cancer have a better starting point for their own questions.
— Wayne Schlicht
Founder, Wayne’s Cancer Journey
Medical disclaimer: I am a cancer patient sharing my personal experience and research. I am not a physician, and nothing on this website should be considered medical advice, diagnosis or a recommendation to use fenbendazole or any other treatment. Always discuss treatment decisions, medications, supplements and repurposed drugs with your qualified medical professionals.
Faith and Caution Hand in Hand
I share my story not as medical advice, but as a testimony to faith, persistence, and open-minded healing. Fenbendazole is still considered experimental, and anyone considering it should consult their oncologist and proceed carefully. For me, it has become one piece of a much larger healing journey—one that combines science, spirituality, and relentless hope.
God’s hand has been evident in my progress. Each day I wake up with gratitude, renewed strength, and a reminder that miracles often come through both medicine and faith.
— Wayne Schlicht
Stage 4 Lung Cancer Survivor and Founder of Wayne’s Cancer Journey
CT scan coming up? Download my FREE CT Scan Week Scanxiety Survival Checklist.
Created by a stage 4 cancer survivor who knows exactly what scan week feels like.
Sources
1. Dogra N, Kumar A, Mukhopadhyay T.
Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways. Scientific Reports. 2018;8:11926.
DOI: 10.1038/s41598-018-30158-6
PMID: 30093705. PMCID: PMC6085345.
Use this source for: Fenbendazole’s effects on microtubules, tubulin, glucose uptake, GLUT transporters, hexokinase II, p53, cancer-cell viability and mouse xenograft experiments.
2. Wang X, Tian W, Wang N, et al.
Transcriptome analysis reveals the anticancer effects of fenbendazole on ovarian cancer: an in vitro and in vivo study. BMC Cancer. 2024;24:1593.
DOI: 10.1186/s12885-024-13361-9
PMID: 39736624.
Use this source for: More recent preclinical evidence investigating fenbendazole’s effects on human ovarian cancer cells, apoptosis, mitotic catastrophe and animal models.
3. U.S. Food and Drug Administration.
FDA Approved Animal Drug Products — Active Ingredients: Fenbendazole. U.S. Food and Drug Administration.
FDA records list multiple veterinary fenbendazole products, including Panacur and Safe-Guard.
Use this source for: Establishing that fenbendazole is an FDA-regulated veterinary drug and identifying its approved animal formulations.
4. U.S. Food and Drug Administration.
Freedom of Information Summary: Safe-Guard and Panacur (Fenbendazole) Suspension 10%, NADA 128-620. U.S. Food and Drug Administration. 2021.
The FDA describes fenbendazole as a benzimidazole antiparasitic drug effective against various nematode parasites and discusses its mechanism involving glucose uptake, energy metabolism and microtubule production in parasites.
Use this source for: Explaining what fenbendazole is, its veterinary uses, its classification as an antiparasitic drug and its established mechanism against parasites.
5. Yamaguchi T, Shimizu J, Oya Y, Horio Y, Hida T.
Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information. Case Reports in Oncology. 2021;14(2):886–891.
DOI: 10.1159/000516276
PMID: 34248555. PMCID: PMC8255718.
Use this source for: Documented human liver injury associated with self-administered fenbendazole and the uncertainty surrounding its safety and tolerability in humans.
6. Severe Drug-Induced Liver Injury Due to Self-administration of the Veterinary Anthelmintic Medication, Fenbendazole.
American College of Gastroenterology Case Reports Journal. 2024.
PMID: 38706451.
This case report describes histologically confirmed severe drug-induced liver injury associated with self-administered fenbendazole, with liver tests returning to normal after fenbendazole was stopped.
Use this source for: Additional evidence that serious liver injury has been reported in humans taking fenbendazole.
7. Krishnan A, Lucas K, Maas L, Woreta TA.
Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis — the importance of structured causality assessment: A case report. World Journal of Clinical Cases. 2026;14(2):116700.
DOI: 10.12998/wjcc.v14.i2.116700
PMID: 41608149. PMCID: PMC12836008.
Use this source for: The particularly important issue of distinguishing fenbendazole-associated liver injury from immune-related hepatitis in patients receiving immune checkpoint inhibitors.
8. Powderly GE, Hassevoort K, Loy M, Balonier J, Sievers C.
Drug-Induced Liver Injury Following Co-ingestion of Veterinary Fenbendazole and Ivermectin for Prostate Cancer: A Case Report. Cureus. 2026;18(5).
DOI: 10.7759/cureus.108896
PMID: 42299164. PMCID: PMC13265026.
Use this source for: A recent case involving severe liver injury following concurrent self-administration of veterinary fenbendazole and ivermectin. Because two drugs were involved, do not use this study to attribute the injury solely to fenbendazole.
9. Satinsky A, Mayer N, Swanson C, Sasso B.
Fenbendazole-Associated Drug-Induced Liver Injury with Concomitant Use of Tauroursodeoxycholic Acid. ACG Case Reports Journal. 2026;13(7).
DOI: 10.14309/crj.0000000000002222
PMID: 42383214. PMCID: PMC13318074.
Use this source for: Additional recent evidence documenting fenbendazole-associated drug-induced liver injury in a human case report.
10. American Cancer Society and American Society of Clinical Oncology.
What to Know About Fenbendazole. American Cancer Society. Published October 21, 2025.
The American Cancer Society explains that fenbendazole is a veterinary antiparasitic drug, has not been FDA approved for humans, and currently lacks adequate human evidence establishing safety and effectiveness as a cancer treatment.
Use this source for: The current clinical context, distinction between preclinical research and human evidence, lack of FDA approval for human cancer treatment, potential risks, and the importance of discussing unproven therapies with the cancer care team.
11. Kim JH, Oh KH, Shin HY, Jun JK.
How cancer patients get fake cancer information: From TV to YouTube, a qualitative study focusing on fenbendazole scandle. Frontiers in Oncology. 2022;12:942045.
DOI: 10.3389/fonc.2022.942045.
Use this source for: Background on how fenbendazole became widely discussed among cancer patients through television, YouTube, social media and other sources of cancer information.
Important Evidence Note
Research involving fenbendazole and cancer remains predominantly preclinical, including laboratory cell experiments and animal models. These studies can identify potentially interesting anticancer mechanisms but do not establish that fenbendazole safely or effectively treats cancer in humans.
Published human literature includes case reports documenting potential adverse effects, particularly liver injury. Fenbendazole is not currently FDA approved as a cancer treatment in humans.
My personal experience with fenbendazole is shared separately from the scientific evidence and should not be interpreted as proof that fenbendazole caused my cancer response.